Perspective Therapeutics
(NYSEMKT) CATX
Perspective Therapeutics Financials at a Glance
Market Cap
$509.28M
Revenue (TTM)
$841.00K
Net Income (TTM)
$103.12M
EPS (TTM)
$-1.39
P/E Ratio
-3.21
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$4.50
Volume
498,371
Open
$4.48
Price
$4.50
Volume
498,371
Open
$4.48
Previous Close
$4.47
Daily Range
$4.39 - $4.51
52-Week Range
$1.75 - $6.16
Dividend
$0.00
Beta (Volatility)
1.21 (Average)
Price
$4.50
Volume
498,371
Open
$4.48
Previous Close
$4.47
Daily Range
$4.39 - $4.51
52-Week Range
$1.75 - $6.16
CATX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Perspective Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
166
CEO
Johan M. Spoor, MBA
Website
perspectivetherapeutics.comHeadquarters
Seattle, WA 99354, US
CATX Financials
Key Financial Metrics (TTM)
Gross Margin
-2%
Operating Margin
11%
Net Income Margin
-123%
Return on Equity
-42%
Return on Capital
4%
Return on Assets
-39%
Earnings Yield
-31.15%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$509.28M
Shares Outstanding
113.93M
Volume
498.37K
Short Interest
0.00%
Avg. Volume
3.41M
Financials (TTM)
Gross Profit
$0.00
Operating Income
$9.14M
EBITDA
$9.14M
Operating Cash Flow
$82.48M
Capital Expenditure
$12.75M
Free Cash Flow
$95.23M
Cash & ST Invst.
$144.74M
Total Debt
$1.63M
Perspective Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$509.28M
N/A
Market Cap/Employee
$3.69M
N/A
Employees
138
N/A
Net Income
$37.49M
+6.7%
EBITDA
$1.55M
+103.7%
Quarterly Fundamentals
Net Cash
$143.11M
-35.8%
Accounts Receivable
$6.00K
-99.6%
Inventory
$0.00
+100.0%
Long Term Debt
$1.00M
-67.1%
Short Term Debt
$623.00K
-38.3%
Return on Assets
-38.63%
N/A
Return on Invested Capital
3.83%
N/A
Free Cash Flow
$13.17M
+68.1%
Operating Cash Flow
$16.69M
+37.3%